UHS: Universal Health Services Corp Enterprise Value to EBITDA Ratio
The EV/EBITDA chart for Universal Health Services (UHS) captures current cyclical profit growth driven by inelastic demand for psychiatric care. IT solutions and AI patient monitoring support this growth, while financial stability is based on the population's fundamental medical needs. The value of 6.77 shows the latest reading of this indicator, helping to assess the real value of the business accounting for the debt load.
uhsinc.com (UHS) - metric breakdowns and financial figures
- stock price and consensus target price:
- market capitalization information:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Universal Health Services|UHS - Long-Term Debt to Equity|Short-Term Debt to Capital Universal Health Services, Inc.|UHS - Company Cumulative Debt|Debt to Book Capitalization Ratio Universal Health Services Corp|UHS - Company Long-Term Loans and Borrowings|Company Short-Term Debt Universal Health Services|Quick Ratio uhsinc.com
- business earnings and investment ratios data:
UHS - Net Profit|Expected Profit Universal Health Services|UHS - Price to Earnings Ratio|Projected Price to Earnings Universal Health Services, Inc.|UHS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Universal Health Services Corp|UHS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Universal Health Services|UHS - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth uhsinc.com|UHS - Earnings growth in current year|Net earnings per share growth forecast for next year Universal Health Services
Initial company analysis:UHS (Universal Health Services Corp)
Optimizing medical supplies at Universal Health Services (UHS) directly impacts operational efficiency, as reflected in the current EV/EBITDA metric. This multiple compares the total enterprise value with earnings before depreciation, taxes, and interest. The calculation accounts for net debt, allowing for an assessment of the real value of assets relative to the generated cash flow. A decrease in this indicator signals that the company is undervalued while maintaining capital stability.
Key competitors
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Health)|FMS: Enterprise Value to EBITDA Ratio|SOLV - EV/EBITDA Multiple|Encompass Health Corporation (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation DVA|RDNT (RadNet Corp) - EV/EBITDA Multiple|Option Care Corp (OPCH) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio SGRY (Surgery Partners, Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PINC (premierinc.com)|EV/EBITDA Multiple EYE (National Vision)|Progyny Inc (PGNY) - Company Value to EBITDA|ARDT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation SEM (Select Medical Inc.)|Astrana Health, Inc. (ASTH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MD - Total Company Value to Operating Income Before Depreciation Ratio|USPH (US Physical Therapy) - EV/EBITDA Multiple|EV/EBITDA Multiple Pennant Group|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Organogenesis Inc. (ORGO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NUTX (Nutex Health Hospitals)|Auna SA - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation SBC|Evolus - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CYH (CHS)|SKIN: EV/EBITDA Multiple|Company Value to EBITDA MediWound (MDWD)|BTMD (biote Corp.) - EV/EBITDA Multiple|EV/EBITDA Multiple thejoint.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DocGo (DCGO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PIII (p3hp.org)|Gain Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio EUDA (euda.com)|Basel Medical Group Limited - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CLGN (CollPlant Biotechnologies)|CUPR (Cuprina Holdings) - Enterprise Value to EBITDA Ratio|Concord Medical Services Holdings - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization American Shared Hospital Services, Inc.|MEDIROM Corp (MRM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ALBT|DHAI - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carmell Therapeutics XAGE|Business Value to Operating Income Before Depreciation NIVF|ATIP: Enterprise Value to EBITDA Ratio|CMAX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KDLY: EV/EBITDA Multiple|MODV - Total Company Value to Operating Income Before Depreciation Ratio|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio SunLink Health Systems, Inc (SSY)|EV/EBITDA Multiple BACK
